Analysis of the Mechanism of Action and Lipid Biomarkers of Jiangzhi Qingshen Capsules in the Treatment of Dyslipidemia Based on Plasma Metabolomics
- VernacularTitle:基于血浆代谢组学研究降脂轻身胶囊治疗血脂异常的作用机制及脂质生物标志物的分析
- Author:
Meng ZHAO
1
;
Rutao BIAN
;
Xiaoyang CHEN
;
Li ZHANG
;
Junpeng ZHANG
;
Xuegong XU
;
Dongyu LI
;
Yi ZHENG
;
Qingrui JIN
Author Information
- Publication Type:Journal Article
- Keywords: Dyslipidaemia; Jiangzhi Qingshen capsules; Metabolomics; Lipid metabolism
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(7):2023-2034
- CountryChina
- Language:Chinese
- Abstract: Objective To investigate the mechanism of action and potential biomarkers of Jiangzhi Qingshen capsules in the treatment of dyslipidaemia based on clinical lipid metabolomics.Methods 30 patients with dyslipidaemia from Zhengzhou Hospital of Chinese Medicine were collected as the test group,and their lipid levels before and after taking Jiang Zhi Qing Shen capsule for 12 weeks were compared.Another 30 healthy patients were enrolled in the physical examination department of Zhengzhou Hospital of Chinese Medicine,and metabolomics investigation was carried out on plasma samples of the test group before and after the treatment as well as those of the healthy patients by LC-MS/MS technology.The differences between the groups were compared by multivariate statistical analysis,and the potential biomarkers were identified by HMDB and lipidblast databases,so as to clarify the possible pathways and targets for the treatment of mild dyslipidaemia by Jiangzhi Qingshen capsules.Results Jiangzhi Qingshen capsules could improve patients' blood lipid level,BMI and abdominal circumference significantly(P<0.05).And metabolomics results showed that 29 lipid metabolites in the plasma of the treated patients were dialled back,which involved cholesterol metabolism,fat digestion and absorption,glycerol-phospholipid metabolism and other biological processes.Conclusion The efficacy of Jiangzhi Qingshen capsules in treating dyslipidaemia was confirmed,and its mechanism of action might be related to the regulation of lipid metabolism.Metabolites such as acylcarnitine(Acar),phosphatidylethanolamine(PE)and phosphatidylcholine(PC)were expected to be used as the biomarkers of dyslipidaemia,so as to provide objective scientific basis for the lipid-lowering capsule,and to facilitate the promotion of its application.
